Chad vs Eritrea: Population requiring preventive chemotherapy for schistosomiasis
Chad
1.91 million
in 2024
Eritrea
813,233
in 2024
Chad rank
33rd
Eritrea rank
36th
Population requiring preventive chemotherapy for schistosomiasis over time
- Chad
- Eritrea
How they compare
Chad currently reports 1.91 million against 813,233 in Eritrea, a difference of 1.09 million.
That makes Chad's figure about 2.3 times Eritrea's.
Across all 15 years both countries report, Chad has been ahead every year.
Chad ranks 33rd and Eritrea ranks 36th of 52 countries.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.57 million | 396,063 | 3.17 million | Chad |
| 2020s | 4.06 million | 526,152 | 3.54 million | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Chad or Eritrea?
- Chad, at 1.91 million against 813,233 in Eritrea as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Chad and Eritrea?
- 1.09 million, with Chad ahead.
- How many years of comparable data are there for Chad and Eritrea?
- 15 years are reported by both, from 2010 to 2024.
- How do Chad and Eritrea rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Chad ranks 33rd and Eritrea ranks 36th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.